The Trump administration has backed away from a blanket ban on a potent kratom-derived opioid, proposing to permit limited amounts in products marketed as natural following an industry lobbying campaign...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.